5//SEC Filing
Hoberman Kenneth 5
Accession 0001104659-20-022141
CIK 0001264587other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 9:32 PM ET
Size
14.7 KB
Accession
0001104659-20-022141
Insider Transaction Report
Form 5
Hoberman Kenneth
Chief Operating Officer
Transactions
- Gift
Stock Options (right to buy)
2019-06-12−18,070→ 0 totalExercise: $2.92Exp: 2021-03-08→ Common Stock (18,070 underlying) - Gift
Stock Options (right to buy)
2019-06-12−18,070→ 0 totalExercise: $2.92From: 2013-01-29Exp: 2021-03-08→ Common Stock (18,070 underlying) - Gift
Stock Options (right to buy)
2019-06-12−97,580→ 0 totalExercise: $3.30Exp: 2022-03-09→ Common Stock (97,580 underlying) - Gift
Stock Options (right to buy)
2019-06-12−75,000→ 0 totalExercise: $5.77Exp: 2026-01-07→ Common Stock (75,000 underlying) - Gift
Stock Options (right to buy)
2019-06-12−132,176→ 0 totalExercise: $4.12Exp: 2026-02-24→ Common Stock (132,176 underlying)
Footnotes (4)
- [F1]On June 12, 2019, options to purchase shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Hoberman's minor children. Mr. Hoberman is not a trustee of the trust and has no investment control over the securities held by the trust.
- [F2]Represents options to purchase shares of common stock that vested 25% per year on each of the first four anniversaries of the grant date. All options have a 10-year life.
- [F3]Represents options to purchase shares of common stock that vested 25% on the first anniversary and the remaining 75% vested quarterly over a three-year period.
- [F4]Represents options to purchase shares of common stock that vested in three equal installments on each of the first three anniversaries of the January 7, 2016 grant date.
Documents
Issuer
STEMLINE THERAPEUTICS INC
CIK 0001264587
Entity typeother
Related Parties
1- filerCIK 0001573722
Filing Metadata
- Form type
- 5
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 9:32 PM ET
- Size
- 14.7 KB